Optimi Health (TSE:OPTI) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Optimi Health Corp., a GMP psychedelics pharmaceutical manufacturer, has successfully shipped its first batch of MDMA to Israel and secured vital Canadian export authorizations, marking a significant expansion in its global operations. The move enhances the company’s ability to supply controlled substances for scientific and therapeutic use worldwide. Additionally, Optimi has engaged Oak Hill Financial Inc. to strengthen investor relations and promote its corporate milestones within the investment community.
For further insights into TSE:OPTI stock, check out TipRanks’ Stock Analysis page.